Publication > Page 70
  • J Clin Oncol  ·  September 19, 2016

    Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

    Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit DB, Feldman DR.

    link out icon
  • Nat Commun  ·  September 8, 2016

    Rare variant phasing and haplotypic expression from RNA sequencing with phASER.

    Castel SE, Mohammadi P, Chung WK, Shen Y, Lappalainen T.

    link out icon
  • Nature  ·  September 5, 2016

    Targeting renal cell carcinoma with a HIF-2 antagonist.

    Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J.

    link out icon
  • Am J Hum Genet  ·  September 1, 2016

    DNA Methylation Profiling of Uniparental Disomy Subjects Provides a Map of Parental Epigenetic Bias in the Human Genome.

    Joshi RS, Garg P, Zaitlen N, Lappalainen T, Watson CT, Azam N, Ho D, Li X, Antonarakis SE, Brunner HG, Buiting K, Cheung SW, Coffee B, Eggermann T, Francis D, Geraedts JP, Gimelli G, Jacobson SG, Le Caignec C, de Leeuw N, Liehr T, Mackay DJ, Montgomery SB, Pagnamenta AT, Papenhausen P, Robinson DO, Ruivenkamp C, Schwartz C, Steiner B, Stevenson DA, Surti U, Wassink T, Sharp AJ.

    link out icon
  • Trends Genet  ·  September 1, 2016

    CRISPR Screens to Discover Functional Noncoding Elements.

    Wright JB, Sanjana NE.

    link out icon
  • Nat Protoc  ·  December 11, 2016

    Indel variant analysis of short-read sequencing data with Scalpel.

    Fang H, Bergmann EA, Arora K, Vacic V, Zody MC, Iossifov I, O’Rawe JA, Wu Y, Jimenez Barron LT, Rosenbaum J, Ronemus M, Lee YH, Wang Z, Dikoglu E, Jobanputra V, Lyon GJ, Wigler M, Schatz MC, Narzisi G.

    link out icon
  • Leukemia  ·  December 2, 2016

    Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.

    Edelmann J, Tausch E, Landau DA, Robrecht S, Bahlo J, Fischer K, Fink AM, Bloehdorn J, Holzmann K, Böttcher S, Werner L, Kneba M, Gribben JG, Neuberg DS, Wu CJ, Hallek M, Döhner H, Stilgenbauer S.

    link out icon
  • Nucleic Acid Res  ·  November 29, 2016

    Pharos: Collating protein information to shed light on the druggable genome.

    Nguyen DT, Mathias S, Bologa C, Brunak S, Fernandez N, Gaulton A, Hersey A, Holmes J, Jensen LJ, Karlsson A, Liu G, Ma’ayan A, Mandava G, Mani S, Mehta S, Overington J, Patel J, Rouillard AD, Schürer S, Sheils T, Simeonov A, Sklar LA, Southall N, Ursu O, Vidovic D, Waller A, Yang J, Jadhav A, Oprea TI, Guha R.

    link out icon
  • J Exp Med  ·  November 18, 2016

    Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs.

    Breton G, Zheng S, Valieris R, Tojal da Silva I, Satija R, Nussenzweig MC.

    link out icon
  • Clin Med Insights Oncol  ·  November 15, 2016

    Key Difficulties Associated with Cancer Biology.

    Fang X, Aragon-Ching J, Cidon EU.

    link out icon
Decorative image color fade left Decorative image color fade right Decorative image color fade